Skip to content

Measurement of Revascularization Effect Using NIRS in BTK Arteries

Measurement of Revascularization Effect Using Near Infrared Spectroscopy in Below the Knee Arteries

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03898869
Enrollment
30
Registered
2019-04-02
Start date
2019-03-29
Completion date
2022-01-31
Last updated
2019-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Feet, Percutaneous Transluminal Angioplasty, Wound Heal

Brief summary

Patient with occluded below the knee arteries and chronic limb ischemia Rutherford class V-VI are enrolled. During endovascular recanalisation procedure changes in tissue oxygen amount is recorded using near infrared spectroscopy (NIRS). Primary hypothesis - NIRS can be used to determine sufficient amount of blood reaching the ulcered ishemic area. Secondary hypothesis - NIRS can be useful in detecting early recoil after BTK recanalisation.

Interventions

DIAGNOSTIC_TESTIntraoperative NIRS monitoring

Near infrared spectroscopy non invasively used to register changes in tissue oxygen amount during endovascular revascularization

Sponsors

Vilnius University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
55 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Critical limb ischemia Rutherford V-VI * At least one artery below the knee is planned to revascularize

Exclusion criteria

* Blood oxygen saturation below 85% because of any comorbidities * Life expectancy less than 12 months * Unavoidable amputation above ankle * Skin diseases preventing the use of NIRS

Design outcomes

Primary

MeasureTime frame
Increase in oxygen amount sufficient for wound healing12 months

Secondary

MeasureTime frame
Detection of early recoil after BTK revascularization1 hour

Countries

Lithuania

Contacts

Primary ContactTomas Baltrūnas
tomas.baltrunas@gmail.com+37052344519

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026